Can a cream regrow hair lost to frontal fibrosing alopecia?
NCT ID NCT07671157
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 2 trial tests a cream called delgocitinib in 30 adults with frontal fibrosing alopecia, a condition that causes hair loss at the front of the scalp. Everyone in the study will use the cream for 24 weeks. Researchers will measure changes in hairline and hair counts to see if the treatment helps.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- delgocitinib cream
- What this could lead to
- If it works, this could point toward a topical treatment to slow or reverse hair loss in frontal fibrosing alopecia.
- What could go wrong
- This is a small, early-phase trial with no placebo group, so results may not be conclusive. The drug may not improve hair growth or could cause skin irritation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRONTAL FIBROSING ALOPECIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lahey Clinic
Burlington, Massachusetts, 01805, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.